IPP Bureau
Shilpa Medicare receives USFDA approval for Bortezomib injection
By IPP Bureau - August 27, 2024
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH
By IPP Bureau - August 27, 2024
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
Bristol Myers Squibb to present data across cardiovascular portfolio at ECS 2024
By IPP Bureau - August 27, 2024
New analyses, including presentations on mavacamten, apixaban and milvexian, further solidify the company's strength and expertise as a leader in cardiovascular diseases
Pfizer launches digital platform ‘PfizerForAll’
By IPP Bureau - August 27, 2024
PfizerForAll works within the existing healthcare system and through a growing network of partners to simplify access via established channels and to close gaps in care
Merck announces Phase 3 trial initiation for Bomedemstat
By IPP Bureau - August 27, 2024
The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs)
Akums appoints Amrut Medhekar as CEO - CDMO Business
By IPP Bureau - August 26, 2024
e brings over 27+ years of rich pharmaceutical experience
Akums Q1 FY25 revenue up 5.1%
By IPP Bureau - August 26, 2024
The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually
Honeywell launches quality management system HQMR for Life Sciences industry
By IPP Bureau - August 26, 2024
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
Shilpa Medicare announces positive outcome of Phase 3 studies of NorUDCA
By IPP Bureau - August 26, 2024
Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India
Royal Sense launches stergic dengue IgG/IgM rapid test
By IPP Bureau - August 25, 2024
The Dengue IgG/IgM Rapid Test is a diagnostic tool used to detect antibodies against the dengue virus in blood samples
Alembic receives FDA final approval for Betamethasone Valerate Foam, 0.12%
By IPP Bureau - August 25, 2024
BioIVT acquires ZenBio
By IPP Bureau - August 25, 2024
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
BI Sky Global successfully completes FDA MoCRA registration
By IPP Bureau - August 25, 2024
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
Fasenra approved in China for the treatment of severe eosinophilic asthma
By IPP Bureau - August 25, 2024
Approval based on MIRACLE Phase III trial demonstrating a significant and clinically meaningful reduction in asthma exacerbations and improvement in asthma symptom control
Zydus to acquire 50% stake in Sterling Biotech from Perfect Day
By IPP Bureau - August 24, 2024
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
